Radiology Devices Move To OIVD: More Cohesive Dx Reviews Ahead?
This article was originally published in The Gray Sheet
Executive Summary
FDA hopes that shuttling its Radiological Devices Branch to the Office of In Vitro Diagnostic Device Evaluation and Safety will produce more cohesive policies on diagnostic device review